Liver injury in chemotherapy (CT)-treated breast, colorectal, and lung cancer (CA) patients (Pts) using automated health data. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I.
LAFAYETTE, Colo.-- The Genome-Wide RNAi Global Initiative (RNAi Global), an alliance of Dharmacon, Inc., and 14 leading international research centers pioneering the use of whole-genome RNAi screening ...
The global pandemic may be over, but SARS-CoV-2 continues to infect people around the world. Indeed, the United States has recorded roughly 750 deaths from COVID-19 over the past month. Now, an siRNA ...
Over the past several years, RNAi screening went through a period of technology development aimed at gaining a better understanding of its advantages and limitations, and there is now an “established ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback